In the present study, we found that tumour DSC2 levels significantly influence the disease-free and overall survival of breast cancer patients, in particular for patients with primary tumours corresponding to the HER2 positive and TNBC molecular subgroups. The gene discussed is ERBB2; the disease is breast cancer.